Immuneering Corp Stock Forward View
| IMRX Stock | USD 5.22 0.03 0.58% |
This Naive Prediction projection for Immuneering Corp is fitted to the equity's recent daily closes. Low error metrics relative to the price level indicate the model fits recent trading behavior well. Older observations carry less weight in the current projection as the price series extends. High SAE relative to the price level signals cumulative forecast drift over the evaluation period. The Naive Prediction model projects Immuneering Corp at 4.93 for the next trading day, below the most recent closing price. This forecast is one analytical input among many and should be assessed in the context of broader analysis.
Immuneering Corp Cash Forecast
Statistical forecasting of Immuneering Corp's financial indicators relies on detecting patterns in past data. Business cycle sensitivity and seasonal effects are factored into forward-looking estimates of Immuneering Corp's position. Statistical pattern recognition reveals recurring cycles in Immuneering Corp's cash generation. Forward-looking estimates are generated with quantified uncertainty ranges.
Cash | First Reported 2020-03-31 | Previous Quarter 227.56 million | Current Value 128.65 million | Quarterly Volatility 46.98 million |
Macro event markers
Naive Prediction Price Forecast For the 11th of May 2026
Over a 90-day horizon, the Naive Prediction model forecasts Immuneering Corp at 4.93 for the next trading day, with a mean absolute deviation of 0.17 , mean absolute percentage error of 0.03 , and sum of absolute errors of 10.14 .This represents a tight forecast with good short-term tracking of Immuneering Corp's price movement. This output is intended for short-term analytical reference.
Stock Forecast Pattern
| Backtest Immuneering Corp | Immuneering Corp Price Prediction | Research Analysis |
Forecasted Value
Immuneering Corp's next-session forecast estimates practical downside and upside boundaries based on the model's historical fit. The projected band runs from roughly 1.51 on the downside to about 8.36 on the upside. The wide range indicates elevated uncertainty in short-term projections.
Model Predictive Factors
The table below summarizes the Naive Prediction model's error metrics for Immuneering Corp stock. Lower MAD and MAPE values indicate tighter forecast accuracy. AIC measures relative model quality — lower values indicate less information loss and a better-fitting model. A large Bias suggests systematic over- or under-prediction.| AIC | Akaike Information Criteria | 115.0441 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1663 |
| MAPE | Mean absolute percentage error | 0.0313 |
| SAE | Sum of the absolute errors | 10.1415 |
Other Forecasting Options for Immuneering Corp
Fibonacci retracement levels applied to Immuneering Corp Stock price swings identify potential support and resistance zones. Extreme price moves in Immuneering Corp occur more frequently than standard risk models assume. Support and resistance levels derived from Immuneering Corp's historical data identify zones where buying or selling pressure has stalled moves. A volume spike without a corresponding price move signals accumulation or distribution ahead of a directional breakout.Immuneering Corp Related Equities
Immuneering Corp's market space within the Health Care space is illustrated by the firms listed below. Checking cash flow across this peer set helps gauge Immuneering Corp's relative financial strength. A stock that beats its peers on many metrics often deserves a closer look from value-focused investors. These links can also guide portfolio spreading choices within the sector.
| Risk & Return | Correlation |
Immuneering Corp Market Strength Events
Rate of Change and Momentum readings for Immuneering Corp measure the velocity of recent price moves rather than direction alone. These indicators add context to how recent sessions in Immuneering Corp have behaved. These indicators are most informative when viewed alongside Immuneering Corp's volume profile and volatility measures. The Price Action Indicator distills each session's open-high-low-close into a single directional score for Immuneering Corp.
Immuneering Corp Risk Indicators
Standard deviation and variance for Immuneering Corp measure total price dispersion, while semi-deviation isolates only the downside moves. Higher variance relative to sector peers signals that Immuneering Corp's price path has been less predictable over the measured period. Analyzing Immuneering Corp's risk indicators helps explain how recent moves compare with its broader trading range. A narrow gap between mean deviation and standard deviation indicates that Immuneering Corp's return distribution is relatively symmetric.
| Mean Deviation | 2.74 | |||
| Semi Deviation | 3.27 | |||
| Standard Deviation | 3.6 | |||
| Variance | 12.95 | |||
| Downside Variance | 12.75 | |||
| Semi Variance | 10.66 | |||
| Expected Short fall | -3.04 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Immuneering Corp Short Properties
Short-interest signals around Immuneering Corp reveal whether skeptical positioning is starting to pressure price predictability and market tone. This is applicable when the question is whether bearish pressure is starting to shape the market's reaction function.
| Common Stock Shares Outstanding | 44.01 million | |
| Cash And Short Term Investments | 172.83 million |